Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases
- PMID: 27761284
- PMCID: PMC5056659
- DOI: 10.5152/balkanmedj.2016.15881
Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases
Abstract
Background: The correlation of S100A8/S100A9 with various inflammatory conditions, including autoimmune diseases have been reported. There is no study investigating the levels of S100A8/S100A9 in autoimmune thyroid diseases (AITD).
Aims: We aimed to evaluate the level of serum S100A8/S100A9 in AITD.
Study design: Case control study.
Methods: Fifty patients with AITD (25 Hashimoto's thyroiditis (HT) and 25 Graves' disease (GD)) were included in the study. Twenty seven healthy subjects participated as a control group. Blood samples were obtained in the 3 months after the initiation of medical treatment. Serum levels of total antioxidant status (TAS), total oxidative status (TOS), total free sulfhydryl (SH), lipid hydroperoxide (LOOH) and S100A8/S100A9 were analyzed.
Results: The patients with AITD had significantly higher S100A8/S100A9, OSI, LOOH and TOS levels than the healthy control group. There was no significant difference between GD and HT patients in terms of S100A8/S100A9, TOS and OSI levels. S100A8/S100A9 level was positively correlated with LOOH, TOS and OSI levels but negatively correlated with -SH level in the patients with AITD.
Conclusion: Serum S100A8/S100A9 levels were increased in patients with AITD and positively correlated with LOOH, TOS and OSI whereas negatively correlated with SH.
Keywords: Autoimmune thyroid disease; S100A8/S100A9; oxidative status.
Conflict of interest statement
No conflict of interest was declared by the authors.
Figures
Similar articles
-
Serum prolidase levels in Graves' disease without ophthalmopathy and its association with oxidative status.J Endocrinol Invest. 2015 Nov;38(11):1167-73. doi: 10.1007/s40618-015-0278-7. Epub 2015 Apr 22. J Endocrinol Invest. 2015. PMID: 25900177
-
Paraoxonase and arylesterase levels in autoimmune thyroid diseases.Redox Rep. 2016 Sep;21(5):227-31. doi: 10.1080/13510002.2015.1107310. Epub 2016 Jan 21. Redox Rep. 2016. PMID: 26795296 Free PMC article.
-
The impact of levothyroxine sodium treatment on oxidative stress in Hashimoto's thyroiditis.Eur J Endocrinol. 2016 Jun;174(6):727-34. doi: 10.1530/EJE-15-1061. Epub 2016 Mar 7. Eur J Endocrinol. 2016. PMID: 26951600
-
Serum calprotectin: a new potential biomarker for thyroid papillary carcinoma.Tumour Biol. 2015 Sep;36(10):7549-56. doi: 10.1007/s13277-015-3468-1. Epub 2015 Apr 29. Tumour Biol. 2015. PMID: 25916207
-
How far are we from understanding the genetic basis of Hashimoto's thyroiditis?Int Rev Immunol. 2013 Jun;32(3):337-54. doi: 10.3109/08830185.2012.755175. Epub 2013 Apr 25. Int Rev Immunol. 2013. PMID: 23617710 Review.
Cited by
-
Aberrant MRP14 expression in thyroid follicular cells mediates chemokine secretion through the IL-1β/MAPK pathway in Hashimoto's thyroiditis.Endocr Connect. 2018 Jun;7(6):850-858. doi: 10.1530/EC-18-0019. Epub 2018 May 15. Endocr Connect. 2018. PMID: 29764904 Free PMC article.
-
Transcriptome analysis of the effect of diosgenin on autoimmune thyroiditis in a rat model.Sci Rep. 2021 Mar 18;11(1):6401. doi: 10.1038/s41598-021-85822-1. Sci Rep. 2021. PMID: 33737640 Free PMC article.
-
Circulating microRNA Expression Profiling Identifies miR-125a-5p Promoting T Helper 1 Cells Response in the Pathogenesis of Hashimoto's Thyroiditis.Front Immunol. 2020 Jun 11;11:1195. doi: 10.3389/fimmu.2020.01195. eCollection 2020. Front Immunol. 2020. PMID: 32595646 Free PMC article.
-
Increased Plasma Levels of S100A8, S100A9, and S100A12 in Chronic Spontaneous Urticaria.Indian J Dermatol. 2019 Nov-Dec;64(6):441-446. doi: 10.4103/ijd.IJD_375_18. Indian J Dermatol. 2019. PMID: 31896840 Free PMC article.
References
-
- Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14:174–180. http://dx.doi.org/10.1016/j.autrev.2014.10.016. - DOI - PubMed
-
- Zarković M. The role of oxidative stress on the pathogenesis of graves’ disease. J Thyroid Res. 2012;2012:302537. http://dx.doi.org/10.1155/2012/302537. - DOI - PMC - PubMed
-
- Marcocci C, Leo M, Altea MA. Oxidative stress in graves’ disease. Eur Thyroid J. 2012;1:80–7. http://dx.doi.org/10.1159/000337976. - DOI - PMC - PubMed
-
- Rostami R, Aghasi MR, Mohammadi A, Nourooz-Zadeh J. Enhanced oxidative stress in Hashimoto’s thyroiditis: interrelationships to biomarkers of thyroid function. Clin Biochem. 2013;46:308–12. http://dx.doi.org/10.1016/j.clinbiochem.2012.11.021. - DOI - PubMed
-
- Stríz I, Trebichavský I. Calprotectin- a pleiotropic molecule in acute and chronic inflammation. Physiol Res. 2004;53:245–53. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous